Literature DB >> 2432405

gp140v-fms molecules expressed at the surface of cells transformed by the McDonough strain of feline sarcoma virus are phosphorylated in tyrosine and serine.

T Tamura, E Simon, H Niemann, G T Snoek, H Bauer.   

Abstract

Cells transformed by the McDonough strain of feline sarcoma virus express at their surface a v-fms-specific transmembrane glycoprotein designated gp140v-fms. By labeling with 32Pi, gp140v-fms was shown to be phosphorylated 30-fold more in serine residues than were the cytosolic v-fms polypeptides gp180gag-fms and gp120v-fms. By using the phosphotyrosine phosphatase-specific inhibitor sodium orthovanadate, an additional tyrosine phosphorylation was observed in vivo, again involving predominantly gp140v-fms. In vitro studies showed that the v-fms proteins were phosphorylated by protein kinase C in a calcium- and phosphatidylserine-dependent manner.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2432405      PMCID: PMC367261          DOI: 10.1128/mcb.6.12.4745-4748.1986

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  16 in total

1.  Subcellular localization of glycoproteins encoded by the viral oncogene v-fms.

Authors:  S J Anderson; M A Gonda; C W Rettenmier; C J Sherr
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

2.  pp60c-src is a substrate for phosphorylation when cells are stimulated to enter cycle.

Authors:  T Tamura; R R Friis; H Bauer
Journal:  FEBS Lett       Date:  1984-11-05       Impact factor: 4.124

3.  Transforming gene product of Rous sarcoma virus phosphorylates tyrosine.

Authors:  T Hunter; B M Sefton
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

4.  Nucleotide sequence of the feline retroviral oncogene v-fms shows unexpected homology with oncogenes encoding tyrosine-specific protein kinases.

Authors:  A Hampe; M Gobet; C J Sherr; F Galibert
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

5.  Transformation by the v-fms oncogene product: role of glycosylational processing and cell surface expression.

Authors:  E J Nichols; R Manger; S Hakomori; A Herscovics; L R Rohrschneider
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

6.  Cell surface expression of the McDonough strain of feline sarcoma virus fms gene product (gp 140fms).

Authors:  R Manger; L Najita; E J Nichols; S Hakomori; L Rohrschneider
Journal:  Cell       Date:  1984-12       Impact factor: 41.582

7.  Antibodies against synthetic peptides as a tool for functional analysis of the transforming protein pp60src.

Authors:  T Tamura; H Bauer; C Birr; R Pipkorn
Journal:  Cell       Date:  1983-09       Impact factor: 41.582

8.  An acid phosphatase in the plasma membranes of human astrocytoma showing marked specificity toward phosphotyrosine protein.

Authors:  J F Leis; N O Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

9.  Gene products of McDonough feline sarcoma virus have an in vitro-associated protein kinase that phosphorylates tyrosine residues: lack of detection of this enzymatic activity in vivo.

Authors:  M Barbacid; A V Lauver
Journal:  J Virol       Date:  1981-12       Impact factor: 5.103

10.  Cell surface expression of v-fms-coded glycoproteins is required for transformation.

Authors:  M F Roussel; C W Rettenmier; A T Look; C J Sherr
Journal:  Mol Cell Biol       Date:  1984-10       Impact factor: 4.272

View more
  10 in total

1.  Influence of tyrosine residues Y705 and Y807 on the transforming potency of the v-fms oncogene product of feline sarcoma virus.

Authors:  S Trouliaris; A Hadwiger-Fangmeier; M Heimann; T Tamura
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

2.  Tyrosine phosphorylations in vivo associated with v-fms transformation.

Authors:  D K Morrison; P J Browning; M F White; T M Roberts
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

3.  FMS mutations in myelodysplastic, leukemic, and normal subjects.

Authors:  S A Ridge; M Worwood; D Oscier; A Jacobs; R A Padua
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

4.  Colony-stimulating factor 1-mediated regulation of a chimeric c-fms/v-fms receptor containing the v-fms-encoded tyrosine kinase domain.

Authors:  M F Roussel; J R Downing; R A Ashmun; C W Rettenmier; C J Sherr
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

5.  Tyrosine 807 of the v-Fms oncogene product controls cell morphology and association with p120RasGAP.

Authors:  S Trouliaris; U Smola; J H Chang; S J Parsons; H Niemann; T Tamura
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

6.  Isolation of a transformation-defective mutant of the McDonough strain of feline sarcoma virus exhibiting tyrosine kinase activity in vitro but not in vivo.

Authors:  T Tamura; D Hennig; M Grell; H Niemann; B Boschek
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

7.  Ligand-induced tyrosine kinase activity of the colony-stimulating factor 1 receptor in a murine macrophage cell line.

Authors:  J R Downing; C W Rettenmier; C J Sherr
Journal:  Mol Cell Biol       Date:  1988-04       Impact factor: 4.272

8.  Detection of fms-oncogene-specific tyrosine kinase activity in human leukemia cells.

Authors:  T Tamura; H Brost; A Käbisch; F Lampert; A Hadwiger-Fangmeier; H Niemann
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

9.  Reassessment of the v-fms sequence: threonine phosphorylation of the COOH-terminal domain.

Authors:  U Smola; D Hennig; A Hadwiger-Fangmeier; B Schütz; E Pfaff; H Niemann; T Tamura
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

10.  Random mutagenesis of CSF-1 receptor (FMS) reveals multiple sites for activating mutations within the extracellular domain.

Authors:  T van Daalen Wetters; S A Hawkins; M F Roussel; C J Sherr
Journal:  EMBO J       Date:  1992-02       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.